Building a national framework for the establishment of regulatory science for drug development: workshop summary
Saved in:
| Format: | Electronic eBook |
|---|---|
| Language: | English |
| Published: |
Washington, D.C.
National Academies Press
c2011
|
| Subjects: | |
| Online Access: | FAW01 FAW02 Volltext |
| Item Description: | "The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it."--Publisher's description Includes bibliographical references (p. 53-55) Introduction -- - Defining regulatory sciences -- - The urgent need for regulatory science -- - Barriers to enhanced regulatory science -- - Potential models for building a regulatory science infrastructure -- - Challenges in engaging the public policy community -- - Envisioning successsful regulatory science at FDA -- - Considering next steps |
| Physical Description: | 1 Online-Ressource (xvi, 78 p.) |
| ISBN: | 0309158893 0309158907 9780309158893 9780309158909 |
Staff View
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043105548 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2011 |||| o||u| ||||||eng d | ||
| 020 | |a 0309158893 |9 0-309-15889-3 | ||
| 020 | |a 0309158907 |c electronic bk. |9 0-309-15890-7 | ||
| 020 | |a 9780309158893 |9 978-0-309-15889-3 | ||
| 020 | |a 9780309158909 |c electronic bk. |9 978-0-309-15890-9 | ||
| 035 | |a (OCoLC)733766580 | ||
| 035 | |a (DE-599)BVBBV043105548 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 353.9/970973 |2 23 | |
| 245 | 1 | 0 | |a Building a national framework for the establishment of regulatory science for drug development |b workshop summary |c Yeonwoo Lebovitz, Rebecca A. English and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| 246 | 1 | 3 | |a Regulatory science for drug development |
| 246 | 1 | 3 | |a Forum on Drug Discovery, Development, and Translation |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c c2011 | |
| 300 | |a 1 Online-Ressource (xvi, 78 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a "The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it."--Publisher's description | ||
| 500 | |a Includes bibliographical references (p. 53-55) | ||
| 500 | |a Introduction -- - Defining regulatory sciences -- - The urgent need for regulatory science -- - Barriers to enhanced regulatory science -- - Potential models for building a regulatory science infrastructure -- - Challenges in engaging the public policy community -- - Envisioning successsful regulatory science at FDA -- - Considering next steps | ||
| 610 | 1 | 7 | |a United States / Food and Drug Administration |2 fast |
| 610 | 1 | 4 | |a United States / Food and Drug Administration |
| 610 | 2 | 4 | |a United States |b Food and Drug Administration |
| 650 | 7 | |a POLITICAL SCIENCE / Government / State & Provincial |2 bisacsh | |
| 650 | 7 | |a Drug development |2 fast | |
| 650 | 4 | |a Drug Discovery / Congresses / United States | |
| 650 | 4 | |a Clinical Trials as Topic / Congresses / United States | |
| 650 | 4 | |a Drug Approval / Congresses / United States | |
| 650 | 4 | |a Drug Evaluation / Congresses / United States | |
| 650 | 4 | |a Drug development |z United States |v Congresses | |
| 651 | 4 | |a USA | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Lebovitz, Yeonwoo |e Sonstige |4 oth | |
| 700 | 1 | |a English, Rebecca A. |e Sonstige |4 oth | |
| 700 | 1 | |a Claiborne, Anne B. |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Forum on Drug Discovery, Development, and Translation |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=359520 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028529739 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=359520 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=359520 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Record in the Search Index
| _version_ | 1804175519833391104 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043105548 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)733766580 (DE-599)BVBBV043105548 |
| dewey-full | 353.9/970973 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 353 - Specific fields of public administration |
| dewey-raw | 353.9/970973 |
| dewey-search | 353.9/970973 |
| dewey-sort | 3353.9 6970973 |
| dewey-tens | 350 - Public administration and military science |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03585nmm a2200589zc 4500</leader><controlfield tag="001">BV043105548</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309158893</subfield><subfield code="9">0-309-15889-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309158907</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-309-15890-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309158893</subfield><subfield code="9">978-0-309-15889-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309158909</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-309-15890-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)733766580</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043105548</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">353.9/970973</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Building a national framework for the establishment of regulatory science for drug development</subfield><subfield code="b">workshop summary</subfield><subfield code="c">Yeonwoo Lebovitz, Rebecca A. English and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Regulatory science for drug development</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Forum on Drug Discovery, Development, and Translation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">c2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xvi, 78 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it."--Publisher's description</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. 53-55)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Introduction -- - Defining regulatory sciences -- - The urgent need for regulatory science -- - Barriers to enhanced regulatory science -- - Potential models for building a regulatory science infrastructure -- - Challenges in engaging the public policy community -- - Envisioning successsful regulatory science at FDA -- - Considering next steps</subfield></datafield><datafield tag="610" ind1="1" ind2="7"><subfield code="a">United States / Food and Drug Administration</subfield><subfield code="2">fast</subfield></datafield><datafield tag="610" ind1="1" ind2="4"><subfield code="a">United States / Food and Drug Administration</subfield></datafield><datafield tag="610" ind1="2" ind2="4"><subfield code="a">United States</subfield><subfield code="b">Food and Drug Administration</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">POLITICAL SCIENCE / Government / State & Provincial</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug development</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Discovery / Congresses / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic / Congresses / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval / Congresses / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation / Congresses / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lebovitz, Yeonwoo</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">English, Rebecca A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Claiborne, Anne B.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Forum on Drug Discovery, Development, and Translation</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=359520</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028529739</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=359520</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=359520</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV043105548 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:17:35Z |
| institution | BVB |
| isbn | 0309158893 0309158907 9780309158893 9780309158909 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028529739 |
| oclc_num | 733766580 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xvi, 78 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Building a national framework for the establishment of regulatory science for drug development workshop summary Yeonwoo Lebovitz, Rebecca A. English and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies Regulatory science for drug development Forum on Drug Discovery, Development, and Translation Washington, D.C. National Academies Press c2011 1 Online-Ressource (xvi, 78 p.) txt rdacontent c rdamedia cr rdacarrier "The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it."--Publisher's description Includes bibliographical references (p. 53-55) Introduction -- - Defining regulatory sciences -- - The urgent need for regulatory science -- - Barriers to enhanced regulatory science -- - Potential models for building a regulatory science infrastructure -- - Challenges in engaging the public policy community -- - Envisioning successsful regulatory science at FDA -- - Considering next steps United States / Food and Drug Administration fast United States / Food and Drug Administration United States Food and Drug Administration POLITICAL SCIENCE / Government / State & Provincial bisacsh Drug development fast Drug Discovery / Congresses / United States Clinical Trials as Topic / Congresses / United States Drug Approval / Congresses / United States Drug Evaluation / Congresses / United States Drug development United States Congresses USA (DE-588)1071861417 Konferenzschrift gnd-content Lebovitz, Yeonwoo Sonstige oth English, Rebecca A. Sonstige oth Claiborne, Anne B. Sonstige oth Institute of Medicine (U.S.) Forum on Drug Discovery, Development, and Translation Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=359520 Aggregator Volltext |
| spellingShingle | Building a national framework for the establishment of regulatory science for drug development workshop summary United States / Food and Drug Administration fast United States / Food and Drug Administration United States Food and Drug Administration POLITICAL SCIENCE / Government / State & Provincial bisacsh Drug development fast Drug Discovery / Congresses / United States Clinical Trials as Topic / Congresses / United States Drug Approval / Congresses / United States Drug Evaluation / Congresses / United States Drug development United States Congresses |
| subject_GND | (DE-588)1071861417 |
| title | Building a national framework for the establishment of regulatory science for drug development workshop summary |
| title_alt | Regulatory science for drug development Forum on Drug Discovery, Development, and Translation |
| title_auth | Building a national framework for the establishment of regulatory science for drug development workshop summary |
| title_exact_search | Building a national framework for the establishment of regulatory science for drug development workshop summary |
| title_full | Building a national framework for the establishment of regulatory science for drug development workshop summary Yeonwoo Lebovitz, Rebecca A. English and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| title_fullStr | Building a national framework for the establishment of regulatory science for drug development workshop summary Yeonwoo Lebovitz, Rebecca A. English and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| title_full_unstemmed | Building a national framework for the establishment of regulatory science for drug development workshop summary Yeonwoo Lebovitz, Rebecca A. English and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| title_short | Building a national framework for the establishment of regulatory science for drug development |
| title_sort | building a national framework for the establishment of regulatory science for drug development workshop summary |
| title_sub | workshop summary |
| topic | United States / Food and Drug Administration fast United States / Food and Drug Administration United States Food and Drug Administration POLITICAL SCIENCE / Government / State & Provincial bisacsh Drug development fast Drug Discovery / Congresses / United States Clinical Trials as Topic / Congresses / United States Drug Approval / Congresses / United States Drug Evaluation / Congresses / United States Drug development United States Congresses |
| topic_facet | United States / Food and Drug Administration United States Food and Drug Administration POLITICAL SCIENCE / Government / State & Provincial Drug development Drug Discovery / Congresses / United States Clinical Trials as Topic / Congresses / United States Drug Approval / Congresses / United States Drug Evaluation / Congresses / United States Drug development United States Congresses USA Konferenzschrift |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=359520 |
| work_keys_str_mv | AT lebovitzyeonwoo buildinganationalframeworkfortheestablishmentofregulatorysciencefordrugdevelopmentworkshopsummary AT englishrebeccaa buildinganationalframeworkfortheestablishmentofregulatorysciencefordrugdevelopmentworkshopsummary AT claiborneanneb buildinganationalframeworkfortheestablishmentofregulatorysciencefordrugdevelopmentworkshopsummary AT instituteofmedicineusforumondrugdiscoverydevelopmentandtranslation buildinganationalframeworkfortheestablishmentofregulatorysciencefordrugdevelopmentworkshopsummary AT lebovitzyeonwoo regulatorysciencefordrugdevelopment AT englishrebeccaa regulatorysciencefordrugdevelopment AT claiborneanneb regulatorysciencefordrugdevelopment AT instituteofmedicineusforumondrugdiscoverydevelopmentandtranslation regulatorysciencefordrugdevelopment AT lebovitzyeonwoo forumondrugdiscoverydevelopmentandtranslation AT englishrebeccaa forumondrugdiscoverydevelopmentandtranslation AT claiborneanneb forumondrugdiscoverydevelopmentandtranslation AT instituteofmedicineusforumondrugdiscoverydevelopmentandtranslation forumondrugdiscoverydevelopmentandtranslation |